Essential parameters to consider for the characterization of optical imaging probes

Nanomedicine

Volumn 7, Issue 7, 2012, Pages 1101-1107

  Leung, Kam ^a   Chopra, Arvind ^a   Shan, Liang ^a   Eckelman, William C ^a   Menkens, Anne E ^b  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

Author keywords

characterization; dyes; MICAD; molecular imaging; nanoparticles; near infrared fluorescence; NIR; optical imaging; organic fluorophores; targeted optical probes

Indexed keywords

NANOPARTICLE;

ARTICLE; BINDING KINETICS; CELL LABELING; CELL LINE; CHEMICAL COMPOSITION; COMPUTER ASSISTED TOMOGRAPHY; DISPERSION; ECHOGRAPHY; HUMAN; HYDRODYNAMICS; IMAGING SYSTEM; IN VITRO STUDY; IN VIVO STUDY; LIGHT INTENSITY; MOLECULAR PROBE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; OPTICAL IMAGING PROBE; OPTICAL INSTRUMENTATION; PARTICLE SIZE; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; QUALITY CONTROL; QUANTUM YIELD; RADIOGRAPHY; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; ZETA POTENTIAL;

ANIMALS; CONTRAST MEDIA; FLUORESCENT DYES; MOLECULAR IMAGING; NANOPARTICLES; OPTICAL IMAGING;

EID: 84864477034     PISSN: 17435889     EISSN: 17486963     Source Type: Journal    
DOI: 10.2217/nnm.12.79     Document Type: Article

References (44)

1. Chopra A, Shan L, Eckelman WC et al. Molecular imaging and contrast agent database (MICAD): evolution and progress. Mol. Imaging Biol. 14(1), 4-13 (2012).
2. Cheng K T, Menkens A, Bryant S, Sullivan DC. NIH MICAD initiative and guest author program opportunities. J. Nucl. Med. 48(5), 19N (2007).
3. Chopra A, Shan L, Eckelman WC, Leung K, Menkens AE. Important parameters to consider for the characterization of PET and SPECT imaging probes. Nucl. Med. Biol. 38(8), 1079-1084 (2011).
4. Hargreaves RJ. The role of molecular imaging in drug discovery and development. Clin. Pharmacol. Ther. 83(2), 349-353 (2008).
5. Pan D, Carauthers SD, Chen J et al. Nanomedicine strategies for molecular targets with MRI and optical imaging. Future Med. Chem. 2(3), 471-490 (2010).
6. Willmann JK, Van Bruggen N, Dinkelborg LM, Gambhir SS. Molecular imaging in drug development. Nat. Rev. Drug Discov. 7(7), 591-607 (2008). (Pubitemid 351927724)
7. Mahmood U. Optical molecular imaging approaches in colorectal cancer. Gastroenterology 138(2), 419-422 (2010).
8. Mahmoudi M, Serpooshan V, Laurent S. Engineered nanoparticles for biomolecular imaging. Nanoscale 3(8), 3007-3026 (2011).
9. Frangioni J V. In vivo near-infrared fuorescence imaging. Curr. Opin. Chem. Biol. 7(5), 626-634 (2003).
10. Gompels LL, Lim NH, Vincent T, Paleolog EM. In vivo optical imaging in arthritis-an enlightening future? Rheumatology (Oxford) 49(8), 1436-1446 (2010).
11. Sevick-Muraca EM, Houston JP, Gurfnkel M. Fluorescence-enhanced, near infrared diagnostic imaging with contrast agents. Curr. Opin. Chem. Biol. 6(5), 642-650 (2002). (Pubitemid 35284196)
12. Bhaumik S, Depuy J, Klimash J. Strategies to minimize background autofuorescence in live mice during noninvasive fuorescence optical imaging. Lab. Anim. (NY) 36(8), 40-43 (2007). (Pubitemid 47326741)
13. McNally JB, Kirkpatrick ND, Hariri LP et al. Task-based imaging of colon cancer in the Apc(Min/+) mouse model. Appl. Opt. 45(13), 3049-3062 (2006). (Pubitemid 43874659)
14. Inoue Y, Izawa K, Kiryu S, Tojo A, Ohtomo K. Diet and abdominal autofuorescence detected by in vivo fuorescence imaging of living mice. Mol. Imaging 7(1), 21-27 (2008).
15. Schantz SP, Alfano RR. Tissue autofuorescence as an intermediate endpoint in cancer chemoprevention trials. J. Cell. Biochem. Suppl. 17F, 199-204 (1993). (Pubitemid 23252942)
16. Frangioni JV. New technologies for human cancer imaging. J. Clin. Oncol. 26(24), 4012-4021 (2008).
17. Pysz MA, Gambhir SS, Willmann JK. Molecular imaging: current status and emerging strategies. Clin. Radiol. 65(7), 500-516 (2010).
18. Yang X, Stein EW, Ashkenazi S, Wang LV. Nanoparticles for photoacoustic imaging. Wiley Interdiscip. Rev. Nanomed. Nanobiotechnol. 1(4), 360-368 (2009).
19. Liu Y, Yu G, Tian M, Zhang H. Optical probes and the applications in multimodality imaging. Contrast Media Mol. Imaging 6(4), 169-177 (2011).
20. Gurfnkel M, Ke S, Wen X, Li C, Sevick-Muraca EM. Near-infrared fuorescence optical imaging and tomography. Dis. Markers 19(2-3), 107-121 (2003). (Pubitemid 38530356)
21. Persigehl T, Heindel W, Bremer C. MR and optical approaches to molecular imaging. Abdom. Imaging 30(3), 342-354 (2005). (Pubitemid 40898067)
22. Rao J, Dragulescu-Andrasi A, Yao H. Fluorescence imaging in vivo: recent advances. Curr. Opin. Biotechnol. 18(1), 17-25 (2007). (Pubitemid 46237739)
23. Achilefu S. Lighting up tumors with receptor-specifc optical molecular probes. Technol. Cancer. Res. Treat. 3(4), 393-409 (2004). (Pubitemid 39096612)
24. Slakter JS, Yannuzzi LA, Guyer DR, Sorenson JA, Orlock DA. Indocyanine-green angiography. Curr. Opin. Ophthalmol. 6(3), 25-32 (1995).
25. Yannuzzi LA. Indocyanine green angiography: a perspective on use in the clinical setting. Am. J. Ophthalmol. 151(5), 745-751, E741 (2011).
26. Yamamoto M, Sasaguri S, Sato T. Assessing intraoperative blood fow in cardiovascular surgery. Surg. Today 41(11), 1467-1474 (2011).
27. Dashti R, Laakso A, Niemela M, Porras M, Hernesniemi J. Microscope integrated indocyanine green video-angiography in cerebrovascular surgery. Acta Neurochir. Suppl. 109, 247-250 (2011).
28. Burra P, Masier A. Dynamic tests to study liver function. Eur. Rev. Med. Pharmacol. Sci. 8(1), 19-21 (2004). (Pubitemid 38659918)
29. Kitano S, Kim YI. ICG clearance in assessing cirrhotic patients with hepatocellular carcinoma for major hepatic resection. HPB Surg. 10(3), 182-183 (1997). (Pubitemid 27197256)
30. Schaafsma BE, Mieog JS, Hutteman M et al. The clinical use of indocyanine green as a near-infrared fuorescent contrast agent for image-guided oncologic surgery. J. Surg. Oncol. 104(3), 323-332 (2011).
31. Polom K, Murawa D, Rho YS, Nowaczyk P, Hunerbein M, Murawa P. Current trends and emerging future of indocyanine green usage in surgery and oncology: a literature review. Cancer 117(21), 4812-4822 (2011).
32. Choi HS, Frangioni JV. Nanoparticles for biomedical imaging: fundamentals of clinical translation. Mol. Imaging 9(6), 291-310 (2010).
33. Weissleder R, Tung CH, Mahmood U, Bogdanov A Jr. In vivo imaging of tumors with protease-activated near-infrared fuorescent probes. Nat. Biotechnol. 17(4), 375-378 (1999). (Pubitemid 29166041)
34. Skotland T, Iversen TG, Sandvig K. New metal-based nanoparticles for intravenous use: requirements for clinical success with focus on medical imaging. Nanomedicine 6(6), 730-737 (2010).
35. Schipper ML, Iyer G, Koh AL et al. Particle size, surface coating, and PEGylation infuence the biodistribution of quantum dots in living mice. Small 5(1), 126-134 (2009).
36. Owens DE 3rd, Peppas NA. Opsonization, biodistribution, and pharmacokinetics of polymeric nanoparticles. Int. J. Pharm. 307(1), 93-102 (2006). (Pubitemid 41773257)
37. Denora N, Trapani A, Laquintana V, Lopedota A, Trapani G. Recent advances in medicinal chemistry and pharmaceutical technology-strategies for drug delivery to the brain. Curr. Top. Med. Chem. 9(2), 182-196 (2009).
38. Proost JH, Roggeveld J, Wierda JM, Meijer DK. Relationship between chemical structure and physicochemical properties of series of bulky organic cations and their hepatic uptake and biliary excretion rates. J. Pharmacol. Exp. Ther. 282(2), 715-726 (1997). (Pubitemid 27340172)
39. Jovanoic MS, Brboric J, Vladimirov S, Suturkova L. Correlation between lipophilicity of the ligands and hepatobiliary properties of the radiopharmaceuticals: approach to the development of new IDA derivatives. J. Radioanalyt. Nucl. Chem. 245(3), 555-560 (2000).
40. Doane TL, Chuang CH, Hill RJ, Burda C. Nanoparticle z-potentials. Acc. Chem. Res. 45(3), 317-326 (2011).
41. Ahualli S, Arroyo FJ, Delgado AV. Consideration of polydispersity in the evaluation of the dynamic mobility of concentrated suspensions. J. Colloid Interface Sci. 343(1), 350-358 (2010).
42. Olafsen T, Wu AM. Antibody vectors for imaging. Semin. Nucl. Med. 40(3), 167-181 (2010).
43. Bhirde A, Xie J, Swierczewska M, Chen X. Nanoparticles for cell labeling. Nanoscale 3(1), 142-153 (2011).
44. Eckelman WC, Kilbourn MR, Joyal JL, Labiris R, Valliant JF. Justifying the number of animals for each experiment. Nucl. Med. Biol. 34(3), 229-232 (2007). (Pubitemid 46442899)